Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1136/annrheumdis-2020-218713 http://scihub22266oqcxt.onion/10.1136/annrheumdis-2020-218713 32796043!ä!32796043 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Ann+Rheum+Dis 2022 ; 81 (10): e191 Nephropedia Template TP {{tp|p=32796043|t=2022. COVID-19 Global Rheumatology Alliance Registry, anti-IL-6 therapy, shared decision-making and patient outcomes Response to: Correspondence on Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry by Gianfrancesco et al Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation prior to advent of clinical trials - a real-world district general hospital experience by Khan et al, Comment on Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry by Gianfrancesco M et al by Andreica et al and COVID-19 outcomes in patients with systemic autoimmune diseases treated with immunomodulatory drugs by Ansarin et al |pdf=|usr=}}{{32796043}} gab.com Text COVID-19 Global Rheumatology Alliance Registry, anti-IL-6 therapy, shared decision-making and patient outcomes Response to: Correspondence on Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry by Gianfrancesco et al Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation prior to advent of clinical trials - a real-world district general hospital experience by Khan et al, Comment on Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry by Gianfrancesco M et al by Andreica et al and COVID-19 outcomes in patients with systemic autoimmune diseases treated with immunomodulatory drugs by Ansarin et al JO: Ann Rheum Dis http://www.kidney.de/pget.php?&tw=1&pmid=32796043 #FOAvip ä Twit Text FOAVip COVID-19 Global Rheumatology Alliance Registry, anti-IL-6 therapy, shared decision-making and patient outcomes Response to: Correspondence on Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry by Gianfrancesco et al Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation prior to advent of clinical trials - a real-world district general hospital experience by Khan et al, Comment on Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry by Gianfrancesco M et al by Andreica et al and COVID-19 outcomes in patients with systemic autoimmune diseases treated with immunomodulatory drugs by Ansarin et al ????Ann Rheum Dis http://www.kidney.de/pget.php?&tw=1&pmid=32796043 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32796043 #FOAvip English Wikipedia <ref>{{Cite pmid|32796043}}</ref> COVID-19 Global Rheumatology Alliance Registry, anti-IL-6 therapy, shared decision-making and patient outcomes Response to: Correspondence on Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry by Gianfrancesco et al Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation prior to advent of clinical trials - a real-world district general hospital experience by Khan et al, Comment on Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry by Gianfrancesco M et al by Andreica et al and COVID-19 outcomes in patients with systemic autoimmune diseases treated with immunomodulatory drugs by Ansarin et al #MMPMID32796043 Gianfrancesco M; Hyrich KL; Yazdany J; Machado PM; Robinson PC Ann Rheum Dis 2022[Oct]; 81 (10): e191 PMID32796043show ga ä |*Autoimmune Diseases[MESH] |*COVID-19 Drug Treatment[MESH] |*Physicians[MESH] |*Rheumatic Diseases/complications/drug therapy[MESH] |*Rheumatology[MESH] |Antibodies, Monoclonal, Humanized[MESH] |Compassionate Use Trials[MESH] |Hospitalization[MESH] |Hospitals, General[MESH] |Humans[MESH] |Immunomodulating Agents[MESH]COVID-19 Global Rheumatology Alliance Registry, anti-IL-6 therapy, sha(epmc).pdf DeepDyve Pubget Overpricing